Upon conclusion of this program, participants should be able to:

• Interpret practice guidelines and identify practice reality needs addressing before clinical practice can consistently reach the desired level of evidence-based practice.
• Discuss the use of ACE-inhibitors and cardiac resynchronization therapy.
• Identify the current recommendations for optimal medical therapy of acute coronary syndromes, as well as understand the selection of the new antithrombin and antiplatelet therapies.
• Identify when to apply new medical and surgical therapies, including biventricular pacing for heart failure.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.